OppenheimerFunds, Inc. - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 203 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.

Quarter-by-quarter ownership
OppenheimerFunds, Inc. ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$97,852,000
+66.8%
3,644,406
+0.4%
0.12%
+45.2%
Q4 2018$58,673,000
-23.9%
3,628,576
-2.3%
0.08%
-6.7%
Q3 2018$77,101,000
+13.3%
3,713,966
-16.7%
0.09%
+11.1%
Q2 2018$68,080,000
-30.3%
4,458,376
+2.6%
0.08%
-33.6%
Q1 2018$97,654,000
-32.6%
4,345,946
-9.7%
0.12%
-30.3%
Q4 2017$144,922,000
-25.1%
4,813,099
-6.3%
0.18%
-26.5%
Q3 2017$193,567,000
+36.8%
5,138,473
+1.3%
0.24%
+36.0%
Q2 2017$141,531,000
-16.3%
5,074,600
+3.2%
0.18%
-14.6%
Q1 2017$169,090,000
+23.5%
4,918,286
+3.6%
0.20%
+18.5%
Q4 2016$136,932,000
-16.4%
4,747,997
-7.8%
0.17%
-16.0%
Q3 2016$163,829,000
+1.1%
5,150,223
+3.2%
0.21%
-3.3%
Q2 2016$162,029,000
+25.1%
4,991,651
+7.8%
0.21%
+23.8%
Q1 2016$129,502,000
-53.8%
4,631,691
-41.0%
0.17%
-3.9%
Q4 2015$280,098,000
+127.9%
7,856,870
+111.4%
0.18%
+7.8%
Q3 2015$122,904,000
-22.4%
3,716,472
-1.7%
0.17%
-8.8%
Q2 2015$158,298,000
+30.9%
3,779,798
+1.9%
0.18%
+34.8%
Q1 2015$120,893,0003,709,5070.14%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Finepoint Capital LP 556,553$11,598,5655.78%
Baker Brothers Advisors 42,864,612$893,298,5145.15%
RTW INVESTMENTS, LP 11,576,537$241,255,0315.09%
Palo Alto Investors LP 2,405,793$50,136,7264.74%
Birchview Capital, LP 240,400$5,009,9364.26%
EcoR1 Capital, LLC 5,991,479$124,862,4224.21%
EMERALD ADVISERS, LLC 1,681,052$35,033,1241.70%
EMERALD MUTUAL FUND ADVISERS TRUST 1,303,988$27,175,1101.64%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 179,702$3,739,5991.26%
SECTOR GAMMA AS 179,785$3,746,7190.96%
View complete list of ACADIA PHARMACEUTICALS INC shareholders